1. Home
  2. HZO vs KALV Comparison

HZO vs KALV Comparison

Compare HZO & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$23.61

Market Cap

604.0M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$15.10

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
KALV
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
604.0M
551.2M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
HZO
KALV
Price
$23.61
$15.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$34.00
$26.43
AVG Volume (30 Days)
378.2K
1.7M
Earning Date
01-22-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,309,288,000.00
$1,426,000.00
Revenue This Year
$4.01
N/A
Revenue Next Year
$4.20
$234.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.85
$7.30
52 Week High
$33.45
$17.28

Technical Indicators

Market Signals
Indicator
HZO
KALV
Relative Strength Index (RSI) 47.79 66.52
Support Level $22.49 $13.28
Resistance Level $25.43 $16.49
Average True Range (ATR) 1.27 1.03
MACD 0.15 0.13
Stochastic Oscillator 49.38 63.32

Price Performance

Historical Comparison
HZO
KALV

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: